Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07889531) titled 'A Multicenter, Prospective, Double-blind, Randomized Controlled Study on the Efficacy and Safety of Ischemic Preconditioning Therapy Versus Optimal Medical Therapy in Reducing the Recurrence of Ischemic Events in Symptomatic Moyamoya Disease' on Oct. 16.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Beijing Tiantan Hospital
Condition:
Moya Moya Disease
Moyamoya Syndrome
Intervention:
Device: remote ischemic conditioning (RIC)
...